SLC6A3 antibody (N-Term)
Quick Overview for SLC6A3 antibody (N-Term) (ABIN965973)
Target
See all SLC6A3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purification
- Purified by antigen-specific affinity chromatography.
-
Immunogen
- Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to N-terminal residues of human DAT(Sodium-dependent dopamine transporter)
-
-
-
-
Application Notes
- ELISA, Western blotting: 1µg/ml for 2hrs.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- This antibody is stored in PBS, 50% glycerol
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
-
-
: "Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding." in: Molecular pharmacology, Vol. 45, Issue 1, pp. 125-35, (1994) (PubMed).
: "A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs." in: Brain research. Molecular brain research, Vol. 15, Issue 1-2, pp. 161-6, (1992) (PubMed).
-
-
- SLC6A3 (Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3))
-
Alternative Name
- DAT
-
Background
- DAT(Sodium-dependent dopamine transporter)is an amine transporter. DAT terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals. This protein is the target of psychomotor stimulants such as amphetamines or cocaine. It belongs to the sodium: neurotransmitter symporter (SNF) family.
-
Pathways
- Dopaminergic Neurogenesis
Target
-